Literature DB >> 20881943

Traditional and non-traditional strategies to optimize catheter function: go with more flow.

Michele H Mokrzycki1, Charmaine E Lok.   

Abstract

In the United States, over 340,000 patients have end-stage renal disease treated by hemodialysis (HD) and are dependent on a reliable vascular access. In over 80% of patients initiating HD, this access is the central venous catheter (CVC). Although the CVC has many advantages that make it desirable for dialysis initiation-ease of insertion, unnecessary maturation time, and availability for immediate use-it is not without significant disadvantages. The substantial morbidity and mortality associated with CVC use has been well documented in the literature. Initiating and maintaining HD patients using a CVC is suboptimal from the perspective of both patient care and associated long-term costs. Yet, in the United States, the most common HD access-related event is replacement of any vascular access type with a CVC. Although in recent years greater effort has be made to reduce CVC use, some patients are unable to have a functioning arteriovenous fistula or graft created due to exhaustion of vessels from previous permanent accesses or limiting comorbidities. In patients dependent on long-term CVC use, the primary problems are due to malfunction ('poor flows') or infection. Catheter malfunction leads to inadequate dialysis, the need for costly and inconvenient intervention, and reduced quality of life. This review will focus on the etiology, prevention, and management of CVC-related malfunction.

Entities:  

Mesh:

Year:  2010        PMID: 20881943     DOI: 10.1038/ki.2010.332

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  The upfront risks of vascular access complications.

Authors:  Louise M Moist; Ahmed A Al-Jaishi
Journal:  J Am Soc Nephrol       Date:  2013-08-22       Impact factor: 10.121

2.  Vascular access: choice and complications in European paediatric haemodialysis units.

Authors:  Wesley N Hayes; Alan R Watson; Nichola Callaghan; Elizabeth Wright; Constantinos J Stefanidis
Journal:  Pediatr Nephrol       Date:  2011-12-30       Impact factor: 3.714

Review 3.  Standardized definitions for hemodialysis vascular access.

Authors:  Timmy Lee; Michele Mokrzycki; Louise Moist; Ivan Maya; Miguel Vazquez; Charmaine E Lok
Journal:  Semin Dial       Date:  2011-09-09       Impact factor: 3.455

4.  Are There Differences in Arteriovenous Fistulae Created for Hemodialysis between Nephrologists and Vascular Surgeons?

Authors:  Radojica V Stolić; Zoran Bukumiric; Vekoslav Mitrovic; Maja Sipic; Biljana Krdzic; Goran Relic; Gordana Nikolic; Sasa Sovtic; Naja E Suljkovic
Journal:  Med Princ Pract       Date:  2020-10-29       Impact factor: 1.927

5.  Dialysis access in a patient with multiple central venous stenoses.

Authors:  Tianlei Cui; Yuliang Zhao; Xiao Li; Li Zhou; Fang Liu; Ping Fu
Journal:  Int Urol Nephrol       Date:  2013-03-26       Impact factor: 2.370

6.  Natural history of tunneled dialysis catheters placed for hemodialysis initiation.

Authors:  Roman Shingarev; Jill Barker-Finkel; Michael Allon
Journal:  J Vasc Interv Radiol       Date:  2013-07-18       Impact factor: 3.464

7.  Use and safety of heparin-free maintenance hemodialysis in the USA.

Authors:  Jenny I Shen; Aya A Mitani; Tara I Chang; Wolfgang C Winkelmayer
Journal:  Nephrol Dial Transplant       Date:  2013-04-05       Impact factor: 5.992

Review 8.  Interventions for treating central venous haemodialysis catheter malfunction.

Authors:  Alice L Kennard; Giles D Walters; Simon H Jiang; Girish S Talaulikar
Journal:  Cochrane Database Syst Rev       Date:  2017-10-26

Review 9.  Renal replacement therapy: a practical update.

Authors:  George Alvarez; Carla Chrusch; Terry Hulme; Juan G Posadas-Calleja
Journal:  Can J Anaesth       Date:  2019-02-06       Impact factor: 5.063

10.  The Clinical and Economic Effect of Vascular Access Selection in Patients Initiating Hemodialysis with a Catheter.

Authors:  Alian Al-Balas; Timmy Lee; Carlton J Young; Jeffrey A Kepes; Jill Barker-Finkel; Michael Allon
Journal:  J Am Soc Nephrol       Date:  2017-07-14       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.